Genomics Research

 
Stock Quotes for Genomics Research top ^
  • Industry: Diagnostics & Research
  • Sector: Healthcare
  • Stock Style: Small Growth
  • Stock Type: Speculative Growth
Sign-up for ghdx investment picks
  • Industry: Diagnostics & Research
  • Sector: Healthcare
  • Stock Style: Small Value
Sign-up for rosg investment picks
  • Industry: Diagnostics & Research
  • Sector: Healthcare
  • Stock Style: Small Growth
  • Stock Type: Speculative Growth
Sign-up for ghdx investment picks

 
ETF Quotes for Genomics Research top ^
  • Holdings: Biogen Idec Inc , Biomarin Pharmaceutical Inc , Illumina Inc , Gilead Sciences Inc , Sigma-Aldrich Corp ,
  • Morningstar Rating: 3 Stars
Sign-up for pbe investment picks

 
News Articles for Genomics Research top ^
2014/12/9
Presentations at SABCS and SUO Reveal Company's Ability to Detect Breast and Bladder Cancers in Blood and Urine, Respectively SAN ANTONIO , Dec.
Sign-up for Genomic Health Advances Development of Novel Liquid Biopsy-Based Cancer Tests investment picks
2015/1/9
NextCODE and WuXi's Genome Center will offer comprehensive clinical, research, and diagnostic testing products and services worldwide SHANGHAI , Jan.
Sign-up for WuXi PharmaTech Acquires NextCODE Health to Create Global Leader in Genomic Medicine investment picks
2015/1/8
Rosetta Genomics Ltd.
Sign-up for Rosetta Genomics Announces Launch of Admera Health’s Sequencing-Based Oncology Tests investment picks
2014/12/10
2014 San Antonio Breast Cancer Symposium Presentation Underscores the Value of Oncotype DX® as Chemotherapy Guide SAN ANTONIO , Dec.
Sign-up for Genomic Health Announces Presentation of First Prospective Outcomes Study of Oncotype DX® Breast Cancer Test investment picks
2014/12/8
BlackBerry Limited (NASDAQ: BBRY; TSX: BB), a global leader in mobile communications, and NantHealth, a cloud-based information technology provider combining science and big data to transform healthcare, today announced the first secure clinical genome browser that gives doctors unprecedented access to patients’ genetic data on the BlackBerry® Passport smartphone – the NantOmics Cancer Genome Browser™. The NantOmics Cancer Genome Browser platform on the BlackBerry Passport enables deep, interactive reporting on genomics data for physicians and other treatment providers in clinical settings – for example, giving oncologists a powerful view into the individual genetic alternations that make each patient’s disease unique and highlighting relevant treatment options.
Sign-up for BlackBerry and NantHealth Launch Breakthrough NantOmics Cancer Genome Browser investment picks
2015/1/22
Sequenom to apply Cypher's Mantis technology for advanced genome interpretation in NIPT SAN DIEGO , Jan.
Sign-up for Cypher Genomics and Sequenom Announce Development Agreement investment picks
2015/2/17
Rosetta Genomics Ltd.
Sign-up for Rosetta Genomics Announces Key Patent Allowances in U.S. and Europe investment picks
2015/1/5
REDWOOD CITY, Calif.
Sign-up for Genomic Health to Present at the 33rd Annual J.P. Morgan Healthcare Conference investment picks
2015/2/26
Rosetta Genomics Ltd.
Sign-up for Rosetta Genomics’ Novel and Differentiated Thyroid Cancer Assay Moves to Advanced Stages of Development investment picks
2015/2/9
Rosetta Genomics Ltd.
Sign-up for Rosetta Genomics Announces Commercial Partnership with Precipio Diagnostics investment picks
2015/1/12
Rosetta Genomics Ltd.
Sign-up for Rosetta Genomics Issues Letter to Shareholders investment picks
2015/2/10
Rosetta Genomics Ltd.
Sign-up for Rosetta Genomics Receives First Patent Allowance in Japan investment picks
2014/12/18
Co-Founder of numerous life science organizations, Terry to lead commercial growth of Claritas's pediatric genetic testing services CAMBRIDGE, Mass.
Sign-up for Claritas Genomics Appoints Patrick F. Terry as Chief Commercial Officer investment picks
2015/1/21
Illumina, Inc. (NASDAQ: ILMN) today announced the launch of the MiSeq FGx Forensic Genomics System , the first fully validated forensic next-generation sequencing (NGS) system, which simultaneously interrogates short tandem repeats (STR) and other valuable genetic markers, including single nucleotide polymorphisms (SNPs), to provide informative DNA profiles.
Sign-up for Illumina Announces First Targeted Next-Generation Sequencing Solution for Forensic Genomics investment picks

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Genomics Research
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Genetic Research  |  Next: Gentiva Health Services